Technical Analysis for SBHMY - Sino Biopharmaceutical ADR

Grade Last Price % Change Price Change
grade A 28.2 -4.24% -1.2500
SBHMY closed down 4.24 percent on Tuesday, September 10, 2019, on 18 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical SBHMY trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
Stochastic Sell Signal Bearish -4.24%
Slingshot Bullish Bullish Swing Setup -4.24%
Narrow Range Bar Range Contraction -4.24%
Wide Bands Range Expansion -4.24%
Overbought Stochastic Strength -4.24%
Gapped Down Weakness -4.24%

Older signals for SBHMY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Sino Biopharmaceutical Limited, researches, develops, manufactures, and sells Chinese medicines and chemical medicines in Hong Kong, Mainland China, and internationally. The company operates in Modernized Chinese Medicines and Chemical Medicines, Investment, and Others segments. Its principal products include hepatitis medicines, such as Runzhong dispersible tablets, Tianqingganmei injections, Tianqingganping enteric capsules, Tianding tablets, Mingzheng capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Kaishi injections, Yilunping and Tuotuo tablets, Tianqingning injections, and Beraprost Sodium tablets; and oncology medicines consisting of Zhiruo, Saiweijian, Tianqingyitai, and Qingweike injections, as well as Shoufu and Yinishu tablets, and Gelike capsules. The company's principal products also include Analgesic medicines, such as Kaifen injections and Zepusi Flurbiprofen Cataplasms; Orthopedic medicines, which comprise New Ossified Triol capsules and Jiuli tablets; anti-infectious medicines, including Tiance injections and Tianjie tablets; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and anorectal medicines comprising Aisuping injections and Getai tablets. In addition, it develops medicines for liver, tumor, cardio-cerebral, analgesia, respiratory system, and orthopedic diseases; engages in the retail and distribution of pharmaceutical products; provides medical management consultancy services; and manufactures, sells, and distributes health food products, as well as is involved in optometry for optical glasses and sale of ophthalmic products. Further, the company provides research and development, medical technology development, and outpatient and surgical procedure services. The company was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.
Natural Sciences Pharmaceutical Industry Health Sciences Medication Pharmaceutical Products Pharmacology Tumor Chemical Engineering Hepatitis Tablet Health Food Products Chemical Medicines Getai Medical Management Consultancy Services Medical Technology Development Ophthalmic Products Orthopedic Diseases Surgical Procedure Services Tai Suke Tianjie Yinishu
Is SBHMY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 33.3533
52 Week Low 11.88
Average Volume 1,115
200-Day Moving Average 0.0
50-Day Moving Average 21.6347
20-Day Moving Average 24.006
10-Day Moving Average 26.4605
Average True Range 1.2627
ADX 22.47
+DI 59.4808
-DI 35.3989
Chandelier Exit (Long, 3 ATRs ) 26.2119
Chandelier Exit (Short, 3 ATRs ) 21.0881
Upper Bollinger Band 30.8316
Lower Bollinger Band 17.1804
Percent B (%b) 0.81
BandWidth 56.865784
MACD Line 2.3958
MACD Signal Line 1.7212
MACD Histogram 0.6746
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.4220
Resistance 3 (R3) 28.3973 28.2987 28.3850
Resistance 2 (R2) 28.2987 28.2421 28.3110 28.3727
Resistance 1 (R1) 28.2493 28.2072 28.2740 28.2740 28.3603
Pivot Point 28.1507 28.1507 28.1630 28.1630 28.1507
Support 1 (S1) 28.1013 28.0941 28.1260 28.1260 28.0397
Support 2 (S2) 28.0027 28.0592 28.0150 28.0273
Support 3 (S3) 27.9533 28.0027 28.0150
Support 4 (S4) 27.9780